Clinical Trial Evaluating External Evaluation and Training on the Incomplete Resection (POLIPEVA Study)

Design

Non-pharmacological clinical trial

Methods

Study population The population of endoscopists under study includes specialists in the digestive system with more than one year of experience in endoscopies.

Candidate patients to be included will be those scheduled to perform a colonoscopy on a non-urgent basis. The patient will be invited to participate prior to the performance of the colonoscopy.

Stages of the study Stage I: estimation of incomplete polypectomies

All participating endoscopists will include polyps in order to perform the baseline estimate. To avoid that the estimation is made on the basis of a small group of participants, a minimum number of lesions will be required and a maximum threshold for polyps will be established. These thresholds will be estimated as follows:

Minimum: sample size / (number of participating endoscopistsx1.5). It can never be less than 25 injuries.

Maximum: sample size / (number of participating endoscopists / 1.5) Once there are a sufficient number of endoscopists who are at the thresholds allowing their samples to reach the established sample size, the end of patient recruitment will be set for the baseline estimate 30 days later. After this period, all endoscopists who do not reach the minimum threshold will be excluded from the study.

Stage II:

Online training course An online course will be offered that will explain the technique for excision of lesions with a cold loop and the importance of complete resection, techniques to determine the edges of the lesion and possible remains at the polypectomy base through images, video clips. and interaction with the speakers.

After the training measures, each endoscopist will proceed to recruit a minimum number of polyps that will be determined based on the sample size reached in phase I. Once the pre-established sample size has been reached, this phase will be closed.

E) Recruitment, procedure and follow-up Patient recruitment is the same in all phases. Patients who meet the inclusion criteria and do not present any exclusion criteria (pre-endoscopic) will be invited to participate in the study. Informed consent will be completed in accordance with law 41/2002 on patient autonomy without thereby altering the relationship with their doctor or causing any harm to their treatment.

Anonymized video clips of all polypectomies will be recorded in each of the phases, including from when the polypectomy loop is inserted into the endoscope until the biopsies are taken from the base of the polyp.

• Endoscopic act The interventions will be carried out in each of the participating centers. The examinations will be carried out under sedation, following the protocols established in each center. Once the lesion is identified, it will be removed using a cold loop. This will be carried out following the usual standards recommended by international companies. If macroscopic remains of the lesion are observed, a fragmented polypectomy should be performed using, in the same way, the cold loop.

Once the polypectomies are completed, its base will be carefully evaluated, taking biopsies 2 random biopsies at the base of the polypectomy, at two of the ends of the eschar.

• Post-endoscopic follow-up In the 5th week post-colonoscopy from the endoscopic examination, the patient will be contacted by telephone to collect possible complications (they will be questioned about visits to the hospital and in a directed way about the most frequent symptoms of the usual complications (fever, bleeding, abdominal pain ), and if so, the medical history will be reviewed to assess the severity of the complication.
• Histological analysis The analysis of the polypectomy specimens will be carried out in each center according to its usual protocol. The analysis of the biopsies of the base of the polyp will be performed centrally by a pathologist with more than 5 years of experience in digestive pathology. Samples from the base of the polyp will be sent from each center for centralized study. The pathologist will be blinded as to the histological diagnosis of the removed polyp. Samples submitted for centralized analysis will not be kept, but will be destroyed once the study is completed according to standard protocols

• Endoscopic act The interventions will be carried out in each of the participating centers. The examinations will be carried out under sedation, following the protocols established in each center. Once the lesion is identified, it will be removed using a cold loop. This will be carried out following the usual standards recommended by international companies. If macroscopic remains of the lesion are observed, a fragmented polypectomy should be performed using, in the same way, the cold loop.

Once the polypectomies are completed, its base will be carefully evaluated, taking biopsies 2 random biopsies at the base of the polypectomy, at two of the ends of the mucosal defect.

F) Sample size According to the results obtained in our previous work, we observed an intra-subject correlation coefficient (taking the endoscopists as subjects) of 0.017.

The sample size will depend on the number of participating endoscopists. Assuming a baseline proportion of incomplete polypectomies of 7.5%, to detect an absolute risk reduction of 3.5% (that is, to identify as different proportions equal to or less than 4%) with an alpha risk of 5% and a 80% power, the required number of polyps will vary depending on the group of participating endoscopists.

According to our previous work, a 2.5% loss should also be assumed. Given that to estimate the proportion of incomplete polypectomies with a margin of error of +/- 1.5% for any value below 3.5%, a maximum of 558 polyps would be needed, in case of presenting a baseline proportion of incomplete polypectomies < 4%, we could estimate the confidence intervals accurately.

G) Data collection All the variables concerning the characteristics of the endoscopist, the patient and the injuries included will be collected in each center. The variables related to the histological diagnosis of the polypectomy specimen will be collected in the same way at the respective center. The variables concerning the follow-up will be collected centrally, through a telephone call that will be made the 5th week after the procedure. The variable related to the histological study of the base of the polyp will be collected centrally by the pathologist in charge of analyzing the samples. The video clips will be stored in a collection created de novo and centralized in the main researcher center

• Post-endoscopic follow-up In the 5th week post-colonoscopy from the endoscopic examination, the patient will be contacted by telephone to collect possible complications (they will be questioned about visits to the hospital and in a directed way about the most frequent symptoms of the usual complications (fever, bleeding, abdominal pain ), and if so, the medical history will be reviewed to assess the severity of the complication.

• Histological analysis The analysis of the polypectomy specimens will be carried out in each center according to its usual protocol. The analysis of the biopsies of the base of the polyp will be performed centrally by a pathologist with more than 5 years of experience in digestive pathology. Samples from the base of the polyp will be sent from each center for centralized study. The pathologist will be blinded as to the histological diagnosis of the removed polyp. Samples submitted for centralized analysis will not be kept, but will be destroyed once the study is completed according to standard protocols.

Data collection The data from the data collection notebooks will be collected anonymously by the main investigator or collaborating investigators, encrypted and dissociated from the clinical information by means of a patient identification code (ID), in a database created by the program Research Electronic Data Capture Tool (RedCap) (17) attached to the Spanish Society of Digestive Endoscopy, which allows coordinating data collection through access from different national centers. Subsequently, for their analysis, they will be merged by the principal investigator or the encrypted and dissociated collaborating investigators, in a database created using the STATA Stata Corporation program. 2013. Stata Statistical Software: Release 13. College Station, Texas: Stata Corporation. The data entered in the database will be encrypted and the database will be protected with a password to which only researchers will have access. The video clips will be completely anonymized and identified by a code, which will be provided by the main researcher. In no case will identifying data of the patient appear in said videos.

The unified file will be kept at the Río Hortega University Hospital and will be kept until the end of the study. Regarding the application of the Organic Law on Data Protection 15/1999 and the Royal Decree 1720/2007 that develops it, it should be noted that the protocol defined in the project aimed at epidemiological analysis determines that the files will record information completely anonymized.

Statistical analysis In the quantitative variables, the arithmetic mean and standard deviation will be calculated (the variables that do not follow a normal distribution according to the Kolmogorov-Smirnov test will be described with median and interquartile range), and the qualitative ones will be expressed as percentages and their intervals of 95% confidence.

The main objective, the difference in the proportion of indicators collected in the reports made with free fields or with standardized reports, will be compared using logistic regression models based on generalized estimating equations (GEE), taking into account the within-subject correlation. .

Among the secondary endpoints, the proportion of complications in both groups, the proportion of fragmented polypectomies and polypectomies that require repositioning will be compared using the homogeneity z-test without using the Yates correction. Multivariate logistic regression techniques will be used to evaluate the factors associated with incomplete polypectomies and those associated with a failed cold polypectomy. The individual evolution of the endoscopists will be displayed graphically. Cumulative summatory learning curves will be used to graphically represent the individual evolution of the endoscopists.

Inclusion criteria

• Patients over 18 years of age scheduled for a non-urgent colonoscopy.

Exclusion criteria

• Absence of lesions <10 mm.
• Contraindication for polypectomy (anticoagulant treatment that cannot be withdrawn, treatment with clopidogrel, coagulopathy or severe thrombocytopenia)
• Loss of polypectomy specimen
• Refusal to participate